ClearPoint Neuro, Inc.

CLPT

Exchange: Nasdaq
Industry: Surgical & Medical Instruments & Apparatus
SEC CIK: 0001285550

SEC filings (opens in a new tab)

No open-market purchases or sales by ClearPoint Neuro, Inc. insiders were filed in the last 90 days; 128 institutions reported holding it in 13F filings for Q2 2026, worth $247.8M in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding ClearPoint Neuro, Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026 All holders in Q1 2026

13F holders of CLPT: Q1 2026 compared with Q2 2026
Measure	Q1 2026	Of which not filed for Q2 2026	Q2 2026	Change
Holders	118	1	128	+11
Shares	13.0M	3.08K	13.9M	+911.0K (+7.0%)
Value	$118.3M	$28.0K	$247.8M	+$129.5M (+109.5%)

1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (22)

Institutions that held ClearPoint Neuro, Inc. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to CLPT in Q2 2026
Institution	Shares	Value	% of portfolio
Compass Financial Management LLC	295,680	$5.27M	0.64%
Pier Capital, LLC	222,761	$3.97M	0.53%
Diametric Capital, LP	123,293	$2.20M	0.23%
Longaeva Partners L.P.	94,910	$1.69M	0.05%
Exome Asset Management LLC	83,636	$1.49M	0.92%
Citadel Advisors LLC	48,688	$868.6K	0.00%
Creative Planning	23,584	$420.7K	0.00%
Valmark Advisers, Inc.	18,352	$327.4K	0.00%
Gordian Capital Singapore Pte Ltd	15,500	$276.5K	0.48%
Mitsubishi UFJ Kokusai Asset Management Co., Ltd.	14,655	$261.4K	0.00%
McIntyre Freedman & Flynn Investment Advisers Inc	13,000	$231.9K	0.14%
Man Group plc	11,950	$213.2K	0.00%
Inscription Capital, LLC	11,306	$201.7K	0.02%
Persistent Asset Partners Ltd	4,204	$75.0K	0.02%
SRS Capital Advisors, Inc.	3,450	$61.5K	0.00%
Caitong International Asset Management Co., Ltd	2,035	$36.3K	0.00%
Quarry LP	74	$1.32K	0.00%
Balyasny Asset Management LLC	50	$892	0.00%
SJS Investment Consulting Inc.	17	$304	0.00%
Rothschild Investment LLC	15	$268	0.00%
Northwestern Mutual Wealth Management Co	10	$178	0.00%
Clearstead Advisors, LLC	1	$18	0.00%

Sold out (11)

Institutions that held ClearPoint Neuro, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of CLPT in Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
SG Americas Securities, LLC	372,356	$3.39M
Marshall Wace, LLP	52,259	$475.6K
Bridgeway Capital Management, LLC	41,992	$382.1K
nVerses Capital, LLC	18,668	$169.9K
HSBC Holdings PLC	14,141	$128.5K
Epacria Capital Partners, LLC	11,729	$106.7K
Dunhill Financial, LLC	1,500	$13.7K
Essential Partners LLC	1,468	$13.4K
Parallel Advisors, LLC	108	$983
Twin Peaks Wealth Advisors, LLC	71	$646
MAI Capital Management	4	$37

Not filed for Q2 2026 yet (1)

Institutions that held ClearPoint Neuro, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CLPT in Q1 2026 that haven't filed for Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
CWM, LLC	3,078	$28.0K